Virtus ETF Advisers LLC - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 45 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q1 2022$115,000
-23.8%
27,536
-5.6%
0.05%
-10.5%
Q4 2021$151,000
-11.2%
29,175
+2.6%
0.06%
-18.6%
Q1 2020$170,000
-60.5%
28,428
-12.7%
0.07%0.0%
Q4 2019$430,000
+110.8%
32,577
+98.7%
0.07%
+70.7%
Q3 2019$204,000
-26.9%
16,398
-5.3%
0.04%
-30.5%
Q2 2019$279,000
+5.3%
17,311
+105.3%
0.06%
-89.5%
Q1 2019$265,000
-15.1%
8,434
-11.2%
0.56%
+964.2%
Q4 2018$312,0009,5020.05%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q3 2019
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,300,000$17,160,0002.55%
Alphabet Inc. 699,352$9,231,0000.56%
DAFNA Capital Management LLC 100,000$1,320,0000.45%
JUPITER ASSET MANAGEMENT LTD 705,356$9,311,0000.29%
Artal Group S.A. 500,000$6,600,0000.26%
Cormorant Asset Management, LP 479,988$6,336,0000.25%
MPM BioImpact LLC 39,740$525,0000.19%
Granahan Investment Management 305,158$4,028,0000.18%
Burrage Capital Management LLC 13,113$173,0000.12%
Vident Investment Advisory, LLC 118,866$1,569,0000.10%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders